GlaxoSmithKline plc (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 122   

Articles published

GSK 43.78 -0.10 (-0.23%)
price chart
HC Stocks Judgment: GlaxoSmithKline plc (ADR) (NYSE:GSK) Perrigo Company plc ...
Shares of GlaxoSmithKline plc (ADR) (NYSE:GSK) ended Friday session in green amid volatile trading. The shares closed up +0.28 points or 0.64% at $43.88 with 2,285,347 shares getting traded.
HC Stocks Buzzer: GlaxoSmithKline plc (ADR) (NYSE:GSK), ACADIA Pharmaceuticals ...
Shares of GlaxoSmithKline plc (ADR) (NYSE:GSK) ended Wednesday session in green amid volatile trading. The shares closed up +0.39 points or 0.89% at $44.10 with 2.22 million shares getting traded.
What's in GlaxoSmithKline plc (ADR) After Today's Gap Up?  Consumer Eagle
Jefferies Upgrades GlaxoSmithKline plc (ADR) to Buy  TheFounders Daily
Can GlaxoSmithKline plc (ADR) Subsist Advair's Patent Expiry
GlaxoSmithKline plc (ADR) (NYSE:GSK) is in dire need of a magical respiratory molecule to patch up the increasing space in its COPD (chronic obstructive pulmonary disease) and asthma portfolio, due to the patent for blockbuster drug Advair approaching ...
GlaxoSmithKline plc (ADR) Moves Ahead in COPD Treatment
GlaxoSmithKline's plc (NYSE:GSK) new inhale formulation has shown comprehensive results when compared to the standard of care (SOC) treatment for patients suffering from chronic obstructive pulmonary disease (COPD).
GlaxoSmithKline (GSK) Stock to Gain on Lung Drug Success in UK Study  Bidness ETC
Glaxo/Innoviva Report Positive COPD Data on Relvar Ellipta
Here is How the US Congress Bill Benefit GlaxoSmithKline plc (ADR), Inovio ...
The list includes Sanofi SA (ADR) (NYSE:SNY) , GlaxoSmithKline Plc (ADR) (NYSE:GSK), Inovio Pharmaceuticals Inc. (NASDAQ:INO), and Takeda Pharmaceutical Co Ltd.
GlaxoSmithKline and Apple Inc: Medicine Meets Technology
Keeping in view the benefits of the kit, GlaxoSmithKline plc (NYSE:GSK) and Purdue Pharma want to get their hands on it and make the best of it while having it on board.
Apple Inc. (NASDAQ:AAPL) Reaches for Enormous Medical Technology Market  CML News
Analyst's Report Recap: GlaxoSmithKline plc (ADR) (NYSE:GSK)
The mean price target for the shares of GlaxoSmithKline plc (ADR) (NYSE:GSK)is at $47.00 while the highest price target suggested by the analysts is $49.00 and low price target is $44.00.
GlaxoSmithKline plc (ADR) (NYSE:GSK) Given $47.00 Consensus Target Price by ...
GlaxoSmithKline plc (ADR) (NYSE:GSK) shares traded -0.02% during the most recent session. Wall Street analysts covering the stock are projecting that the stock will reach $47.00 within the next 52-weeks.
GlaxoSmithKline plc (ADR) (NYSE:GSK): Look out for Analyst's Recommendation
GlaxoSmithKline plc (ADR) (NYSE:GSK) has grabbed the attention from analysts, when it saw a value increase of 1.13 percent in the last trading session.
HC Stocks Outlines: GlaxoSmithKline plc (ADR) (NYSE:GSK), Opko Health Inc ...
Shares of GlaxoSmithKline plc (ADR) (NYSE:GSK) ended Monday session in green amid volatile trading. The shares closed up +0.31 points or 0.71% at $44.23 with 3.35 million shares getting traded.